Plant polyphenols: How to translate their in vitro antioxidant actions to in vivo conditions

IUBMB Life

Volumn 59, Issue 4-5, 2007, Pages 308-315

  Fraga, Cesar G ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c Department of Nutrition ^*  (United States)

Author keywords

Antioxidant; Flavan 3 ols; Flavonoids; Hypertension; Oxygen radicals; Vascular health

Indexed keywords

ANTIOXIDANT; CATECHIN; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; FLAVANOL DERIVATIVE; FLAVANONE; FLAVONE; FLAVONOID; FREE RADICAL; ISOFLAVONE; POLYPHENOL; PROCYANIDIN; PROCYANIDIN DERIVATIVE; QUERCETIN; SCAVENGER; TANNIN;

ANTIOXIDANT ACTIVITY; CACAO; CANCER; CARDIOVASCULAR DISEASE; CHEMICAL BOND; CONFERENCE PAPER; DEGENERATIVE DISEASE; DIABETES MELLITUS; DRUG STRUCTURE; FRUIT; GENE EXPRESSION; GLUCURONIDATION; HUMAN; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR MECHANICS; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN INTERACTION; STRUCTURE ACTIVITY RELATION; TEA; VEGETABLE; WINE;

ANTIOXIDANTS; CELL MEMBRANE; CHELATING AGENTS; FLAVONOIDS; FREE RADICAL SCAVENGERS; HUMANS; HYPERTENSION; MOLECULAR STRUCTURE; PHENOLS; PLANT PROTEINS; PLANTS;

EID: 34248572037     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1080/15216540701230529     Document Type: Conference Paper

References (99)

1. Bazzano, L. A., He, J., Ogden, L. G., Loria, C. M., Vupputuri, S., Myers, L., and Whelton, P. K. (2002) Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Am. J. Clin. Nutr. 76, 93-99.
2. Hung, H. C., Joshipura, K. J., Jiang, R., Hu, F. B., Hunter, D., Smith-Warner, S. A., Colditz, G. A., Rosner, B., Spiegelman, D., and Willett, W. C. (2004) Fruit and vegetable intake and risk of major chronic disease. J. Natl. Cancer Inst. 96, 1577-1584.
3. Rimm, E. B. (2002) Fruit and vegetables - building a solid foundation. Am. J. Clin. Nutr. 76, 1-2.
4. Renaud, S., and de Lorgeril, M. (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339, 1523-1526.
5. Crozier, A., Jaganath, I. B., and Clifford, M. N. (2006) Phenols, polyphenols and tannins: an overview. In Plant Secondary Metabolites (Crozier, A., Clifford, M. N., and Ashihara, H., eds.) pp. 1-24, Blackwell Publishing Ltd, Oxford.
6. Bors, W., Michel, C., and Stettmaier, K. (1997) Antioxidant effects of flavonoids. Biofactors 6, 399-402.
7. Morand, C., Crespy, V., Manach, C., Besson, C., Demigne, C., and Remesy, C. (1998) Plasma metabolites of quercetin and their antioxidant properties. Am. J. Physiol. 275, R212-219.
8. Salah, N., Miller, N. J., Paganga, G., Tijburg, L., Bolwell, G. P., and Rice-Evans, C. (1995) Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch. Biochem. Biophys. 322, 339-346.
9. Lotito, S. B., Actis-Goretta, L., Renart, M. L., Caligiuri, M., Rein, D., Schmitz, H. H., Steinberg, F. M., Keen, C. L., and Fraga, C. G. (2000) Influence of oligomer chain length on the antioxidant activity of procyanidins. Biochem. Biophys. Res. Commun. 276, 945-951.
10. Guo, Q., Zhao, B., Li, M., Shen, S., and Xin, W. (1996) Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes. Biochim. Biophys. Acta 1304, 210-222.
11. Radi, R. (2004) Nitric oxide, oxidants, and protein tyrosine nitration. Proc. Natl. Acad. Sci. USA 101, 4003-4008.
12. Erlejman, A. G., Verstraeten, S. V., Fraga, C. G., and Oteiza, P. I. (2004) The interaction of flavonoids with membranes: potential determinant of flavonoid antioxidant effects. Free Radic. Res. 38, 1311-1320.
13. Verstraeten, S. V., Hammerstone, J. F., Keen, C. L., Fraga, C. G., and Oteiza, P. I. (2005) Antioxidant and membrane effects of procyanidin dimers and trimers isolated from peanut and cocoa. J. Agric. Food. Chem. 53, 5041-5048.
14. Verstraeten, S. V., Keen, C. L., Schmitz, H. H., Fraga, C. G., and Oteiza, P. I. (2003) Flavan-3-ols and procyanidins protect liposomes against lipid oxidation and disruption of the bilayer structure. Free Radic. Biol. Med. 34, 84-92.
15. Fraga, C. G., Martino, V. S., Ferraro, G. E., Coussio, J. D., and Boveris, A. (1987) Flavonoids as antioxidants evaluated by in vitro and in situ liver chemiluminescence. Biochem. Pharmacol. 36, 717-720.
16. Lotito, S. B., and Fraga, C. G. (1998) (+)-Catechin prevents human plasma oxidation. Free Radic. Biol. Med. 24, 435-441.
17. Lotito, S. B., and Fraga, C. G. (2000) Catechins delay lipid oxidation and alpha-tocopherol and beta-carotene depletion following ascorbate depletion in human plasma. Proc. Soc. Exp. Biol. Med. 225, 32-38.
18. Erlejman, A. G., Fraga, C. G., and Oteiza, P. I. (2006) Procyanidins protect Caco-2 cells from bile acid- and oxidant-induced damage. Free Radic. Biol. Med. 41, 1247-1256.
19. Mackenzie, G. G., Carrasquedo, F., Delfino, J. M., Keen, C. L., Fraga, C. G., and Oteiza, P. I. (2004) Epicatechin, catechin, and dimeric procyanidins inhibit PMA-induced NF-kappaB activation at multiple steps in Jurkat T cells. Faseb J. 18, 167-169.
20. Actis-Goretta, L., Mackenzie, G. G., Oteiza, P. I., and Fraga, C. G. (2002) Comparative study on the antioxidant capacity of wines and other plant-derived beverages. Ann. N. Y. Acad. Sci. 957, 279-283.
21. Kurosawa, T., Itoh, F., Nozaki, A., Nakano, Y., Katsuda, S., Osakabe, N., Tsubone, H., Kondo, K., and Itakura, H. (2005) Suppressive effect of cocoa powder on atherosclerosis in Kurosawa and Kusanagi-hypercholesterolemic rabbits. J. Atheroscler. Thromb. 12, 20-28.
22. Miller, K. B., Stuart, D. A., Smith, N. L., Lee, C. Y., McHale, N. L., Flanagan, J. A., Ou, B., and Hurst, W. J. (2006) Antioxidant activity and polyphenol and procyanidin contents of selected commercially available cocoa-containing and chocolate products in the United States. J. Agric. Food. Chem. 54, 4062-4068.
23. Videla, L. A., Fraga, C. G., Koch, O. R., and Boveris, A. (1983) Chemiluminescence of the in situ rat liver after acute ethanol intoxication - effect of (+)-cyanidanol-3. Biochem. Pharmacol. 32, 2822-2825.
24. Orozco, T. J., Wang, J. F., and Keen, C. L. (2003) Chronic consumption of a flavanol- and procyanindin-rich diet is associated with reduced levels of 8-hydroxy-2′-deoxyguanosine in rat testes. J. Nutr. Biochem. 14, 104-110.
25. Osakabe, N., Natsume, M., Adachi, T., Yamagishi, M., Hirano, R., Takizawa, T., Itakura, H., and Kondo, K. (2000) Effects of cacao liquor polyphenols on the susceptibility of low-density lipoprotein to oxidation in hypercholesterolemic rabbits. J. Atheroscler. Thromb. 7, 164-168.
26. Conseil, G., Baubichon-Cortay, H., Dayan, G., Jault, J. M., Barron, D., and Di Pietro, A. (1998) Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein. Proc. Natl. Acad. Sci. USA 95, 9831-9836.
27. Lancon, A., Delma, D., Osman, H., Thenot, J. P., Jannin, B., and Latruffe, N. (2004) Human hepatic cell uptake of resveratrol: involvement of both passive diffusion and carrier-mediated process. Biochem. Biophys. Res. Commun. 316, 1132-1137.
28. Rosenkranz, S., Knirel, D., Dietrich, H., Flesch, M., Erdmann, E., and Bohm, M. (2002) Inhibition of the PDGF receptor by red wine flavonoids provides a molecular explanation for the 'French paradox'. Faseb J. 16, 1958-1960.
29. Tachibana, H., Koga, K., Fujimura, Y., and Yamada, K. (2004) A receptor for green tea polyphenol EGCG. Nat. Struct. Mol. Biol. 11, 380-381.
30. Verstraeten, S. V., Oteiza, P. I., and Fraga, C. G. (2004) Membrane effects of cocoa procyanidins in liposomes and Jurkat T cells. Biol. Res. 37, 293-300.
31. Oteiza, P. I., Erlejman, A. G., Verstraeten, S. V., Keen, C. L., and Fraga, C. G. (2005) Flavonoid-membrane interactions: a protective role of flavonoids at the membrane surface? Clin. Dev. Immunol. 12, 19-25.
32. Guang, H. M., and Du, G. H. (2006) Protections of pinocembrin on brain mitochondria contribute to cognitive improvement in chronic cerebral hypoperfused rats. Eur. J. Pharmacol. 542, 77-83.
33. Hansen, R. S., Paulsen, I., and Davies, M. (2005) Determinants of amentoflavone interaction at the GABA(A) receptor. Eur. J. Pharmacol. 519, 199-207.
34. Cermak, R., Kuhn, G., and Wolffram, S. (2002) The flavonol quercetin activates basolateral K(+) channels in rat distal colon epithelium. Br. J. Pharmacol. 135, 1183-1190.
35. Cermak, R., Wolffram, S., and Kuhn, G. (2004) Effect of the flavonol quercetin on membrane conductances in rat colonic crypt cells. Eur. J. Pharmacol. 503, 31-34.
36. Schuier, M., Sies, H., Illek, B., and Fischer, H. (2005) Cocoa-related flavonoids inhibit CFTR-mediated chloride transport across T84 human colon epithelia. J. Nutr. 135, 2320-2325.
37. Luck, G., Liao, H., Murray, N. J., Grimmer, H. R., Warminski, E. E., Williamson, M. P., Lilley, T. H., and Haslam, E. (1994) Polyphenols, astringency and proline-rich proteins. Phytochemistry 37, 357-371.
38. Hagerman, A. E., and Butler, L. G. (1981) The specificity of proanthocyanidin-protein interactions. J. Biol. Chem. 256, 4494-4497.
39. Middleton, E., Jr., Kandaswami, C., and Theoharides, T. C. (2000) The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 52, 673-751.
40. Schewe, T., Kuhn, H., and Sies, H. (2002) Flavonoids of cocoa inhibit recombinant human 5-lipoxygenase. J. Nutr. 132, 1825-1829.
41. Schewe, T., Sadik, C., Klotz, L. O., Yoshimoto, T., Kuhn, H., and Sies, H. (2001) Polyphenols of cocoa: inhibition of mammalian 15-lipoxygenase. Biol. Chem. 382, 1687-1696.
42. Kim, S. Y., Ahn, B. H., Min, K. J., Lee, Y. H., Joe, E. H., and Min, D. S. (2004) Phospholipase D isozymes mediate epigallocatechin gallate-induced cyclooxygenase-2 expression in astrocyte cells. J. Biol. Chem. 279, 38125-38133.
43. Oak, M. H., El Bedoui, J., Anglard, P., and Schini-Kerth, V. B. (2004) Red wine polyphenolic compounds strongly inhibit pro-matrix metalloproteinase-2 expression and its activation in response to thrombin via direct inhibition of membrane type 1-matrix metalloproteinase in vascular smooth muscle cells. Circulation 110, 1861-1867.
44. Actis-Goretta, L., Ottaviani, J. I., and Fraga, C. G. (2006) Inhibition of angiotensin converting enzyme activity by flavanol-rich foods. J. Agric. Food. Chem. 54, 229-234.
45. Actis-Goretta, L., Ottaviani, J. I., Keen, C. L., and Fraga, C. G. (2003) Inhibition of angiotensin converting enzyme (ACE) activity by flavan-3-ols and procyanidins. FEBS Lett. 555, 597-600.
46. Ottaviani, J. I., Actis-Goretta, L., Villordo, J. J., and Fraga, C. G. (2005) Procyanidin structure defines the extent and specificity of angiotensin I converting enzyme inhibition. Biochimie 88, 359-365.
47. Ndiaye, M., Chataigneau, T., Andriantsitohaina, R., Stoclet, J. C., and Schini-Kerth, V. B. (2003) Red wine polyphenols cause endothelium-dependent EDHF-mediated relaxations in porcine coronary arteries via a redox-sensitive mechanism. Biochem. Biophys. Res. Commun. 310, 371-377.
48. Ottaviani, J. I., Carrasquedo, F., Keen, C. L., Lazarus, S. A., Schmitz, H. H., and Fraga, C. G. (2002) Influence of flavan-3-ols and procyanidins on UVC-mediated formation of 8-oxo-7,8-dihydro-2′-deoxyguanosine in isolated DNA. Arch. Biochem. Biophys. 406, 203-208.
49. Khan, N., Afaq, F., Saleem, M., Ahmad, N., and Mukhtar, H. (2006) Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res. 66, 2500-2505.
50. Afaq, F., Adhami, V. M., Ahmad, N., and Mukhtar, H. (2003) Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal humanepidermal keratinocytes by green tea Constituent (-)-epigallocatechin-3- gallate. Oncogene 22, 1035-1044.
51. Wheeler, D. S., Catravas, J. D., Odoms, K., Denenberg, A., Malhotra, V., and Wong, H. R. (2004) Epigallocatechin-3-gallate, a green teaderived polyphenol, inhibits IL-1 beta-dependent proinflammatory signal transduction in cultured respiratory epithelial cells. J. Nutr. 134, 1039-1044.
52. Yang, F., de Villiers, W. J., McClain, C. J., and Varilek, G. W. (1998) Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. J. Nutr. 128, 2334-2340.
53. Chen, A., Zhang, L., Xu, J., and Tang, J. (2002) The antioxidant (-)-epigallocatechin-3-gallate inhibits activated hepatic stellate cell growth and suppresses acetaldehyde-induced gene expression. Biochem. J. 368, 695-704.
54. Yang, F., Oz, H. S., Barve, S., de Villiers, W. J., McClain, C. J., and Varilek, G. W. (2001) The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6. Mol. Pharmacol. 60, 528-533.
55. Gupta, S., Hastak, K., Afaq, F., Ahmad, N., and Mukhtar, H. (2004) Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis. Oncogene 23, 2507-2522.
56. Mackenzie, G. G., and Oteiza, P. I. (2006) Modulation of transcription factor NF-kB in Hodgkin's lymphoma cell lines: effect of (-)-epicatechin Free Rad. Res. 40, 1086-1094.
57. Rice-Evans, C. (2001) Flavonoid antioxidants. Curr. Med. Chem. 8, 797-807.
58. Rein, D., Lotito, S., Holt, R. R., Keen, C. L., Schmitz, H. H., and Fraga, C. G. (2000) Epicatechin in human plasma: in vivo determination and effect of chocolate consumption on plasma oxidation status. J. Nutr. 130, 2109S-2114S.
59. Serafini, M., Bugianesi, R., Maiani, G., Valtuena, S., De Santis, S., and Crozier, A. (2003) Plasma antioxidants from chocolate. Nature 424, 1013.
60. Wang, J. F., Schramm, D. D., Holt, R. R., Ensunsa, J. L., Fraga, C. G., Schmitz, H. H., and Keen, C. L. (2000) A dose-response effect from chocolate consumption on plasma epicatechin and oxidative damage. J. Nutr. 130, 2115S-2119S.
61. Fraga, C. G., Actis-Goretta, L., Ottaviani, J. I., Carrasquedo, F., Lotito, S. B., Lazarus, S., Schmitz, H. H., and Keen, C. L. (2005) Regular consumption of a flavanol-rich chocolate can improve oxidant stress in young soccer players. Clin. Dev. Immunol. 12, 11-17.
62. Osakabe, N., Baba, S., Yasuda, A., Iwamoto, T., Kamiyama, M., Takizawa, T., Itakura, H., and Kondo, K. (2001) Daily cocoa intake reduces the susceptibility of low-density lipoprotein to oxidation as demonstrated in healthy human volunteers. Free Radic. Res. 34, 93-99.
63. Wan, Y., Vinson, J. A., Etherton, T. D., Proch, J., Lazarus, S. A., and Kris-Etherton, P. M. (2001) Effects of cocoa powder and dark chocolate on LDL oxidative susceptibility and prostaglandin concentrations in humans. Am. J. Clin. Nutr. 74, 596-602.
64. Kondo, K., Hirano, R., Matsumoto, A., Igarashi, O., and Itakura, H. (1996) Inhibition of LDL oxidation by cocoa. Lancet 348, 1514.
65. Holt, R. R., Lazarus, S. A., Sullards, M. C., Zhu, Q. Y., Schramm, D. D., Hammerstone, J. F., Fraga, C. G., Schmitz, H. H., and Keen, C. L. (2002) Procyanidin dimer B2 [epicatechin-(4beta-8)-epicatechin] in human plasma after the consumption of a flavanol-rich cocoa. Am. J. Clin. Nutr. 76, 798-804.
66. Schroeter, H., Heiss, C., Balzer, J., Kleinbongrad, P., Keen, C. L., Hollenberg, N. K., Sies, H., Kwik-Uribe, C. L., Schmitz, H. H., and Kelm, M. (2006) (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc. Nat. Acad. Sci. USA. 103, 1024-1029.
67. Fraga, C. G. (2005) Cocoa, diabetes, and hypertension: should we eat more chocolate? Am. J. Clin. Nutr. 81, 541-542.
68. Arts, I. C., Jacobs, D. R., Jr., Harnack, L. J., Gross, M., and Folsom, A. R. (2001) Dietary catechins in relation to coronary heart disease death among postmenopausal women. Epidemiology 12, 668-675.
69. Geleijnse, J. M., Launer, L. J., Hofman, A., Pols, H. A., and Witteman, J. C. (1999) Tea flavonoids may protect against atherosclerosis: the Rotterdam Study. Arch. Intern. Med. 159, 2170-2174.
70. Hertog, M. G., Feskens, E. J., Hollman, P. C., Katan, M. B., and Kromhout, D. (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342, 1007-1011.
71. Hertog, M. G., Kromhout, D., Aravanis, C., Blackburn, H., Buzina, R., Fidanza, F., Giampaoli, S., Jansen, A., Menotti, A., Nedeljkovic, S., et al. (1995) Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch. Intern. Med. 155, 381-386.
72. Mennen, L. I., Sapinho, D., de Bree, A., Arnault, N., Bertrais, S., Galan, P., and Hercberg, S. (2004) Consumption of foods rich in flavonoids is related to a decreased cardiovascular risk in apparently healthy French women. J. Nutr. 134, 923-926.
73. Yochum, L., Kushi, L. H., Meyer, K., and Folsom, A. R. (1999) Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. Am. J. Epidemiol. 149, 943-949.
74. Buijsse, B., Feskens, E. J., Kok, F. J., and Kromhout, D. (2006) Cocoa intake, blood pressure, and cardiovascular mortality: the Zutphen Elderly Study. Arch. Intern. Med. 166, 411-417.
75. McCullough, M. L., Chevaux, K., Jackson, L., Preston, M., Martinez, G., Schmitz, H. H., Coletti, C., Campos, H., and Hollenberg, N. K. (2006) Hypertension, the Kuna, and the epidemiology of flavanols. J. Cardiovasc. Pharmacol. 47, S103-109.
76. Grassi, D., Lippi, C., Necozione, S., Desideri, G., and Ferri, C. (2005) Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. Am. J. Clin. Nutr. 81, 611-614.
77. Grassi, D., Necozione, S., Lippi, C., Croce, G., Valeri, L., Pasqualetti, P., Desideri, G., Blumberg, J. B., and Ferri, C. (2005) Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension 46, 398-405.
78. Taubert, D., Berkels, R., Roesen, R., and Klaus, W. (2003) Chocolate and blood pressure in elderly individuals with isolated systolic hypertension. J. Am. Med. Assoc. 290, 1029-1030.
79. Engler, M. B., Engler, M. M., Chen, C. Y., Malloy, M. J., Browne, A., Chiu, E. Y., Kwak, H. K., Milbury, P., Paul, S. M., Blumberg, J., and Mietus-Snyder, M. L. (2004) Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults. J. Am. Coll. Nutr. 23, 197-204.
80. Fisher, N. D., and Hollenberg, N. K. (2006) Aging and vascular responses to flavanol-rich cocoa. J. Hypertens. 24, 1575-1580.
81. Fisher, N. D., Hughes, M., Gerhard-Herman, M., and Hollenberg, N. K. (2003) Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans. J. Hypertens. 21, 2281-2286.
82. Heiss, C., Dejam, A., Kleinbongard, P., Schewe, T., Sies, H., and Kelm, M. (2003) Vascular effects of cocoa rich in flavan-3-ols. J. Am. Med. Assoc. 290, 1030-1031.
83. Heiss, C., Kleinbongard, P., Dejam, A., Perre, S., Schroeter, H., Sies, H., and Kelm, M. (2005) Acute consumption of flavanol-rich cocoa and the reversal of endothelial dysfunction in smokers. J. Am. Coll. Cardiol. 46, 1276-1283.
84. Vlachopoulos, C., Aznaouridis, K., Alexopoulos, N., Economou, E., Andreadou, I., and Stefanadis, C. (2005) Effect of dark chocolate on arterial function in healthy individuals. Am. J. Hypertens. 18, 785-791.
85. Diebolt, M., Bucher, B., and Andriantsitohaina, R. (2001) Wine polyphenols decrease blood pressure, improve NO vasodilatation, and induce gene expression. Hypertension 38, 159-165.
86. Foppa, M., Fuchs, F. D., Preissler, L., Andrighetto, A., Rosito, G. A., and Duncan, B. B. (2002) Red wine with the noon meal lowers postmeal blood pressure: a randomized trial in centrally obese, hypertensive patients. J. Stud. Alcohol. 63, 247-251.
87. Hashimoto, M., Kim, S., Eto, M., Iijima, K., Ako, J., Yoshizumi, M., Akishita, M., Kondo, K., Itakura, H., Hosoda, K., Toba, K., and Ouchi, Y. (2001) Effect of acute intake of red wine on flow-mediated vasodilatation of the brachial artery. Am. J. Cardiol. 88, 1457-1460, A1459.
88. Duffy, S. J., Keaney, J. F., Jr., Holbrook, M., Gokce, N., Swerdloff, P. L., Frei, B., and Vita, J. A. (2001) Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 104, 151-156.
89. Hodgson, J. M., Devine, A., Puddey, I. B., Chan, S. Y., Beilin, L. J., and Prince, R. L. (2003) Tea intake is inversely related to blood pressure in older women. J. Nutr. 133, 2883-2886.
90. Yang, Y. C., Lu, F. H., Wu, J. S., Wu, C. H., and Chang, C. J. (2004) The protective effect of habitual tea consumption on hypertension. Arch. Intern. Med. 164, 1534-1540.
91. Dzau, V. J., Bernstein, K., Celermajer, D., Cohen, J., Dahlof, B., Deanfield, J., Diez, J., Drexler, H., Ferrari, R., Van Gilst, W., Hansson, L., Hornig, B., Husain, A., Johnston, C., Lazar, H., Lonn, E., Luscher, T., Mancini, J., Mimran, A., Pepine, C., Rabelink, T., Remme, W., Ruilope, L., Ruzicka, M., Schunkert, H., Swedberg, K., Unger, T., Vaughan, D., and Weber, M. (2002) Pathophysiologic and therapeutic importance of tissue ACE: a consensus report. Cardiovasc. Drugs Ther. 16, 149-160.
92. Cai, H., and Harrison, D. G. (2000) Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 87, 840-844.
93. de Cavanagh, E. M., Inserra, F., Toblli, J., Stella, I., Fraga, C. G., and Ferder, L. (2001) Enalapril attenuates oxidative stress in diabetic rats. Hypertension 38, 1130-1136.
94. Bormann, H., and Melzig, M. F. (2000) Inhibition of metallopeptidases by flavonoids and related compounds. Pharmazie 55, 129-132.
95. Cyrino, L. A., Cardoso, R. C., Hackl, L. P., and Nicolau, M. (2002) Effect of quercetin on plasma extravasation in rat CNS and dura mater by ACE and NEP inhibition. Phytother. Res. 16, 545-549.
96. Packer, L., Rimbach, G., and Virgili, F. (1999) Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol. Free Radic. Biol. Med. 27, 704-724.
97. Wagner, H., and Elbl, G. (1992) ACE-inhibitory procyanidins from Lespedeza capitata. Planta Med. 58, 297.
98. Lacaille, D., Franck, U., and Wagner, H. (2001) Search for potential angiotensin converting enzyme (ACE)-inhibitors from plants. Phytomedicine 8, 47-52.
99. Aviram, M., and Dornfeld, L. (2001) Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosis 158, 195-198.